Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial. (2023)
Attributed to:
Mesenchymal stem cell-derived extracellular vesicles as a cell-free therapy for ARDS.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1164/rccm.202302-0297oc
PubMed Identifier: 37154608
Publication URI: http://europepmc.org/abstract/MED/37154608
Type: Journal Article/Review
Volume: 208
Parent Publication: American journal of respiratory and critical care medicine
Issue: 3
ISSN: 1073-449X